Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 521

1.

Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.

Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, Price VH, Van Neste D, Roberts JL, Hordinsky M, Shapiro J, Binkowitz B, Gormley GJ.

J Am Acad Dermatol. 1998 Oct;39(4 Pt 1):578-89.

PMID:
9777765
2.

Finasteride in the treatment of men with frontal male pattern hair loss.

Leyden J, Dunlap F, Miller B, Winters P, Lebwohl M, Hecker D, Kraus S, Baldwin H, Shalita A, Draelos Z, Markou M, Thiboutot D, Rapaport M, Kang S, Kelly T, Pariser D, Webster G, Hordinsky M, Rietschel R, Katz HI, Terranella L, Best S, Round E, Waldstreicher J.

J Am Acad Dermatol. 1999 Jun;40(6 Pt 1):930-7.

PMID:
10365924
3.

The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.

Drake L, Hordinsky M, Fiedler V, Swinehart J, Unger WP, Cotterill PC, Thiboutot DM, Lowe N, Jacobson C, Whiting D, Stieglitz S, Kraus SJ, Griffin EI, Weiss D, Carrington P, Gencheff C, Cole GW, Pariser DM, Epstein ES, Tanaka W, Dallob A, Vandormael K, Geissler L, Waldstreicher J.

J Am Acad Dermatol. 1999 Oct;41(4):550-4.

PMID:
10495374
4.

Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.

Price VH, Roberts JL, Hordinsky M, Olsen EA, Savin R, Bergfeld W, Fiedler V, Lucky A, Whiting DA, Pappas F, Culbertson J, Kotey P, Meehan A, Waldstreicher J.

J Am Acad Dermatol. 2000 Nov;43(5 Pt 1):768-76.

PMID:
11050579
5.

Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss.

Roberts JL, Fiedler V, Imperato-McGinley J, Whiting D, Olsen E, Shupack J, Stough D, DeVillez R, Rietschel R, Savin R, Bergfeld W, Swinehart J, Funicella T, Hordinsky M, Lowe N, Katz I, Lucky A, Drake L, Price VH, Weiss D, Whitmore E, Millikan L, Muller S, Gencheff C, et al.

J Am Acad Dermatol. 1999 Oct;41(4):555-63.

PMID:
10495375
6.

Finasteride improves male pattern hair loss in a randomized study in identical twins.

Stough DB, Rao NA, Kaufman KD, Mitchell C.

Eur J Dermatol. 2002 Jan-Feb;12(1):32-7.

PMID:
11809593
7.

Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss.

Whiting DA, Olsen EA, Savin R, Halper L, Rodgers A, Wang L, Hustad C, Palmisano J; Male Pattern Hair Loss Study Group.

Eur J Dermatol. 2003 Mar-Apr;13(2):150-60.

PMID:
12695131
8.

Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia.

Finasteride Male Pattern Hair Loss Study Group.

Eur J Dermatol. 2002 Jan-Feb;12(1):38-49.

PMID:
11809594
9.

Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily.

Price VH, Menefee E, Sanchez M, Ruane P, Kaufman KD.

J Am Acad Dermatol. 2002 Apr;46(4):517-23.

PMID:
11907500
10.

Finasteride increases anagen hair in men with androgenetic alopecia.

Van Neste D, Fuh V, Sanchez-Pedreno P, Lopez-Bran E, Wolff H, Whiting D, Roberts J, Kopera D, Stene JJ, Calvieri S, Tosti A, Prens E, Guarrera M, Kanojia P, He W, Kaufman KD.

Br J Dermatol. 2000 Oct;143(4):804-10.

PMID:
11069460
11.

Effects of finasteride (1 mg) on hair transplant.

Leavitt M, Perez-Meza D, Rao NA, Barusco M, Kaufman KD, Ziering C.

Dermatol Surg. 2005 Oct;31(10):1268-76, discussion 1276.

PMID:
16188178
12.

Finasteride in the treatment of Japanese men with male pattern hair loss.

Kawashima M, Hayashi N, Igarashi A, Kitahara H, Maeguchi M, Mizuno A, Murata Y, Nogita T, Toda K, Tsuboi R, Ueki R, Yamada M, Yamazaki M, Matsuda T, Natsumeda Y, Takahashi K, Harada S.

Eur J Dermatol. 2004 Jul-Aug;14(4):247-54.

PMID:
15319158
13.

Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients.

Kaufman KD, Girman CJ, Round EM, Johnson-Levonas AO, Shah AK, Rotonda J.

Eur J Dermatol. 2008 Jul-Aug;18(4):407-11. doi: 10.1684/ejd.2008.0435. Epub 2008 Jun 23.

PMID:
18573713
14.

The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.

Olsen EA, Hordinsky M, Whiting D, Stough D, Hobbs S, Ellis ML, Wilson T, Rittmaster RS; Dutasteride Alopecia Research Team.

J Am Acad Dermatol. 2006 Dec;55(6):1014-23.

PMID:
17110217
15.

Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results.

Price VH, Menefee E, Sanchez M, Kaufman KD.

J Am Acad Dermatol. 2006 Jul;55(1):71-4. Epub 2006 May 3.

PMID:
16781295
16.

Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women.

Trüeb RM; Swiss Trichology Study Group.

Dermatology. 2004;209(3):202-7.

PMID:
15459533
18.

Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.

Camacho FM, García-Hernández MJ, Fernández-Crehuet JL.

Br J Dermatol. 2008 May;158(5):1121-4. doi: 10.1111/j.1365-2133.2008.08509.x. Epub 2008 Mar 20.

PMID:
18363752
19.

Finasteride, a Type 2 5alpha-reductase inhibitor, in the treatment of men with androgenetic alopecia.

Kaufman KD, Dawber RP.

Expert Opin Investig Drugs. 1999 Apr;8(4):403-15.

PMID:
15992088
20.

Androgens and alopecia.

Kaufman KD.

Mol Cell Endocrinol. 2002 Dec 30;198(1-2):89-95. Review.

PMID:
12573818
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk